4 Lung Cancer Clinical Trials in Providence, RI (2026)

Q: How do I join a clinical trial in Providence?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you.

Recruiting Lung Cancer Studies in Providence

NCT06996782Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in combination with standard therapy for the treatment...

Providence, RIPHASE1152 participantsAstraZeneca

View Study Details

NCT06465329Recruiting

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

This study will enroll adult participants with early-stage (stage II-IIIB) non-small cell lung cancer for whom surgery is planned. The aim is to find out whether an investigational treatment (consist...

Providence, RIPHASE2120 participantsRegeneron Pharmaceuticals

View Study Details

NCT04680377Recruiting

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

This phase IV study is hoping to determine if examining the microbiome in non-small cell lung cancer participants who will receive durvalumab can predict treatment toxicity....

Providence, RI44 participantsJun Zhang, MD, PhD

View Study Details

NCT04933903Recruiting

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

This single-arm phase 2 study will enroll patients with resectable and operable stage IB - III non-small cell lung cancer and treat them with pre-operative ipilimumab + nivolumab plus low-dose stereot...

Providence, RIPHASE225 participantsBrown University

View Study Details

About Lung Cancer Clinical Trials in Providence

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 4 lung cancer clinical trials recruiting participants in Providence, RI. These studies are seeking a combined 341 participants. Research is being sponsored by AstraZeneca, Regeneron Pharmaceuticals, Jun Zhang, MD, PhD and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Providence — FAQ

Are there lung cancer clinical trials in Providence?

Yes, there are 4 lung cancer clinical trials currently recruiting in Providence, RI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Providence?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you about next steps.

Are clinical trials in Providence free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Providence studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 4 active trials in Providence are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated July 19, 2026 from ClinicalTrials.gov